IBDEI3DN ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,56772,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,56772,1,3,0)
 ;;=3^Asymptomatic Varicose Veins Bil LE
 ;;^UTILITY(U,$J,358.3,56772,1,4,0)
 ;;=4^I83.93
 ;;^UTILITY(U,$J,358.3,56772,2)
 ;;=^5008022
 ;;^UTILITY(U,$J,358.3,56773,0)
 ;;=I89.0^^261^2831^111
 ;;^UTILITY(U,$J,358.3,56773,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,56773,1,3,0)
 ;;=3^Lymphedema NEC
 ;;^UTILITY(U,$J,358.3,56773,1,4,0)
 ;;=4^I89.0
 ;;^UTILITY(U,$J,358.3,56773,2)
 ;;=^5008073
 ;;^UTILITY(U,$J,358.3,56774,0)
 ;;=I87.2^^261^2831^163
 ;;^UTILITY(U,$J,358.3,56774,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,56774,1,3,0)
 ;;=3^Venous Insufficiency
 ;;^UTILITY(U,$J,358.3,56774,1,4,0)
 ;;=4^I87.2
 ;;^UTILITY(U,$J,358.3,56774,2)
 ;;=^5008047
 ;;^UTILITY(U,$J,358.3,56775,0)
 ;;=K55.0^^261^2831^32
 ;;^UTILITY(U,$J,358.3,56775,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,56775,1,3,0)
 ;;=3^AC Intestine Vascular Disorders
 ;;^UTILITY(U,$J,358.3,56775,1,4,0)
 ;;=4^K55.0
 ;;^UTILITY(U,$J,358.3,56775,2)
 ;;=^5008705
 ;;^UTILITY(U,$J,358.3,56776,0)
 ;;=K55.1^^261^2831^69
 ;;^UTILITY(U,$J,358.3,56776,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,56776,1,3,0)
 ;;=3^Chr Intestine Vascular Disorders
 ;;^UTILITY(U,$J,358.3,56776,1,4,0)
 ;;=4^K55.1
 ;;^UTILITY(U,$J,358.3,56776,2)
 ;;=^5008706
 ;;^UTILITY(U,$J,358.3,56777,0)
 ;;=N18.9^^261^2831^70
 ;;^UTILITY(U,$J,358.3,56777,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,56777,1,3,0)
 ;;=3^Chr Kidney Disease,Unspec
 ;;^UTILITY(U,$J,358.3,56777,1,4,0)
 ;;=4^N18.9
 ;;^UTILITY(U,$J,358.3,56777,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,56778,0)
 ;;=N28.0^^261^2831^102
 ;;^UTILITY(U,$J,358.3,56778,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,56778,1,3,0)
 ;;=3^Kidney Ischemia & Infarction
 ;;^UTILITY(U,$J,358.3,56778,1,4,0)
 ;;=4^N28.0
 ;;^UTILITY(U,$J,358.3,56778,2)
 ;;=^5015626
 ;;^UTILITY(U,$J,358.3,56779,0)
 ;;=L03.114^^261^2831^61
 ;;^UTILITY(U,$J,358.3,56779,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,56779,1,3,0)
 ;;=3^Cellulitis Lt Upper Limb
 ;;^UTILITY(U,$J,358.3,56779,1,4,0)
 ;;=4^L03.114
 ;;^UTILITY(U,$J,358.3,56779,2)
 ;;=^5009034
 ;;^UTILITY(U,$J,358.3,56780,0)
 ;;=L03.113^^261^2831^63
 ;;^UTILITY(U,$J,358.3,56780,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,56780,1,3,0)
 ;;=3^Cellulitis Rt Upper Limb
 ;;^UTILITY(U,$J,358.3,56780,1,4,0)
 ;;=4^L03.113
 ;;^UTILITY(U,$J,358.3,56780,2)
 ;;=^5009033
 ;;^UTILITY(U,$J,358.3,56781,0)
 ;;=L03.115^^261^2831^62
 ;;^UTILITY(U,$J,358.3,56781,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,56781,1,3,0)
 ;;=3^Cellulitis Rt Lower Limb
 ;;^UTILITY(U,$J,358.3,56781,1,4,0)
 ;;=4^L03.115
 ;;^UTILITY(U,$J,358.3,56781,2)
 ;;=^5009035
 ;;^UTILITY(U,$J,358.3,56782,0)
 ;;=L03.116^^261^2831^60
 ;;^UTILITY(U,$J,358.3,56782,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,56782,1,3,0)
 ;;=3^Cellulitis Lt Lower Limb
 ;;^UTILITY(U,$J,358.3,56782,1,4,0)
 ;;=4^L03.116
 ;;^UTILITY(U,$J,358.3,56782,2)
 ;;=^5133645
 ;;^UTILITY(U,$J,358.3,56783,0)
 ;;=L97.119^^261^2831^121
 ;;^UTILITY(U,$J,358.3,56783,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,56783,1,3,0)
 ;;=3^Non-Pressure Chr Ulcer Rt Thigh
 ;;^UTILITY(U,$J,358.3,56783,1,4,0)
 ;;=4^L97.119
 ;;^UTILITY(U,$J,358.3,56783,2)
 ;;=^5009489
 ;;^UTILITY(U,$J,358.3,56784,0)
 ;;=L97.129^^261^2831^117
 ;;^UTILITY(U,$J,358.3,56784,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,56784,1,3,0)
 ;;=3^Non-Pressure Chr Ulcer Lt Thigh
 ;;^UTILITY(U,$J,358.3,56784,1,4,0)
 ;;=4^L97.129
 ;;^UTILITY(U,$J,358.3,56784,2)
 ;;=^5009494
 ;;^UTILITY(U,$J,358.3,56785,0)
 ;;=L97.219^^261^2831^118
 ;;^UTILITY(U,$J,358.3,56785,1,0)
 ;;=^358.31IA^4^2
